• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FLT3基因在人白血病淋巴瘤细胞系中的表达。

Expression of the FLT3 gene in human leukemia-lymphoma cell lines.

作者信息

DaSilva N, Hu Z B, Ma W, Rosnet O, Birnbaum D, Drexler H G

机构信息

Department of Human and Animal Cell Cultures, Braunschweig, Germany.

出版信息

Leukemia. 1994 May;8(5):885-8.

PMID:8182945
Abstract

The FLT3 gene encodes a protein that appears to function as a receptor for a hematopoietic growth factor; together with the KIT and FMS receptors, FLT3 belongs to the superfamily of receptors with tyrosine kinase activity. We examined the expression of FLT3 mRNA in 36 human leukemia-lymphoma cell lines using Northern blot analysis. FLT3 transcripts were found in seven of seven pre B-ALL cell lines (derived from cases with pre B-acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast crisis), and in one of six B-cell lines (namely in a cell line established from a hairy cell leukemia). FLT3 message was not detected in five T-cell, five myeloid, four monocytic, four erythroid and five megakaryocytic cell lines. Two major mRNA species were expressed differentially by positive cell lines. KIT mRNA expression was also investigated in the same panel of cell lines, but was found only in cell lines with erythroid and megakaryocytic features (and not in any of the FLT3-positive cell lines). The pattern of expression of FLT3 contrasts with the transcription of FMS and KIT and suggests that the FLT3 product may play a role primary in immature lymphoid cells.

摘要

FLT3基因编码一种蛋白质,该蛋白质似乎作为造血生长因子的受体发挥作用;FLT3与KIT和FMS受体一起,属于具有酪氨酸激酶活性的受体超家族。我们使用Northern印迹分析检测了36种人白血病淋巴瘤细胞系中FLT3 mRNA的表达。在7种前B-ALL细胞系(源自前B急性淋巴细胞白血病或慢性髓性白血病淋巴细胞母细胞危象病例)的所有细胞系中,以及6种B细胞系中的1种(即源自毛细胞白血病建立的细胞系)中发现了FLT3转录本。在5种T细胞系、5种髓细胞系、4种单核细胞系、4种红系细胞系和5种巨核细胞系中未检测到FLT3信息。两种主要的mRNA种类在阳性细胞系中差异表达。还在同一组细胞系中研究了KIT mRNA的表达,但仅在具有红系和巨核细胞特征的细胞系中发现(在任何FLT3阳性细胞系中均未发现)。FLT3的表达模式与FMS和KIT的转录形成对比,表明FLT3产物可能主要在未成熟淋巴细胞中发挥作用。

相似文献

1
Expression of the FLT3 gene in human leukemia-lymphoma cell lines.FLT3基因在人白血病淋巴瘤细胞系中的表达。
Leukemia. 1994 May;8(5):885-8.
2
Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.FLT3受体和FLT3配体在人白血病-淋巴瘤细胞系中的表达。
Leukemia. 1995 Aug;9(8):1368-72.
3
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.白血病细胞中FLT3受体的表达及对FLT3配体的反应。
Leukemia. 1996 Apr;10(4):588-99.
4
Expression of the flt3 receptor and its ligand on hematopoietic cells.造血细胞上flt3受体及其配体的表达。
Leukemia. 1995 Jul;9(7):1212-8.
5
Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.白血病-淋巴瘤细胞系中bcl-2 mRNA和蛋白的表达
Leukemia. 1995 Nov;9(11):1841-6.
6
Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines.血小板生成素及血小板生成素受体MPL在人白血病-淋巴瘤及实体瘤细胞系中的表达
Leuk Res. 1996 Oct;20(10):831-8. doi: 10.1016/s0145-2126(96)00057-4.
7
Characterization of the monocyte-specific esterase (MSE) gene.单核细胞特异性酯酶(MSE)基因的特征分析
Leukemia. 1994 Sep;8(9):1510-26.
8
Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.FLT3配体对人白血病细胞的作用。I. 髓系白血病细胞的增殖反应。
Leukemia. 1996 Feb;10(2):261-70.
9
Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.血小板生成素:其受体MPL的表达及对白血病细胞的增殖作用。
Leukemia. 1996 Sep;10(9):1405-21.
10
Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.急性髓性白血病母细胞中III型受体酪氨酸激酶FLT3和KIT的表达及其对其配体的反应。
Leukemia. 1996 Oct;10(10):1584-91.

引用本文的文献

1
Doxorubicin-Loaded Polymeric Micelles Conjugated with CKR- and EVQ-FLT3 Peptides for Cytotoxicity in Leukemic Stem Cells.与CKR和EVQ-FLT3肽偶联的载阿霉素聚合物胶束对白血病干细胞的细胞毒性作用
Pharmaceutics. 2022 Oct 4;14(10):2115. doi: 10.3390/pharmaceutics14102115.
2
Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.用于治疗FLT3过表达白血病细胞的载姜黄素FLT3特异性聚合物胶束的研发与表征
J Pharm Sci. 2016 Dec;105(12):3645-3657. doi: 10.1016/j.xphs.2016.09.010. Epub 2016 Oct 14.
3
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
受体酪氨酸激酶(c-Kit)抑制剂:癌细胞中的一个潜在治疗靶点。
Drug Des Devel Ther. 2016 Aug 1;10:2443-59. doi: 10.2147/DDDT.S89114. eCollection 2016.
4
An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment.FLT3-酪氨酸激酶受体在急性髓系白血病中的作用概述:生物学与治疗
Oncol Rev. 2012 Apr 17;6(1):e8. doi: 10.4081/oncol.2012.e8. eCollection 2012 Mar 5.
5
FLT3 INHIBITORS: RECENT ADVANCES AND PROBLEMS FOR CLINICAL APPLICATION.FLT3抑制剂:临床应用的最新进展与问题
Nagoya J Med Sci. 2015 Feb;77(1-2):7-17.
6
FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.在慢性粒单核细胞白血病小鼠模型中,FLT3突变赋予多能祖细胞增强的增殖和存活特性。
Cancer Cell. 2007 Oct;12(4):367-80. doi: 10.1016/j.ccr.2007.08.031.
7
Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.伴有FLT3突变的急性白血病的生物学特性、临床相关性及分子靶向治疗
Int J Hematol. 2006 May;83(4):301-8. doi: 10.1532/IJH97.06071.
8
Clinical significance of FLT3 in leukemia.FLT3在白血病中的临床意义。
Int J Hematol. 2005 Aug;82(2):85-92. doi: 10.1532/IJH97.05066.